• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags FDA

    Tag: FDA

    President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)
    Healthcare

    Trump aims to take on ‘slow’ FDA

    Robert King -
    March 1, 2017 2:40 am
    0
    Activists were horrified to hear of a push to make the medical abortion pill widely available. (AP Photo/Manuel Balce Ceneta)
    Healthcare

    Activists aghast as FDA asked to give abortion pill to pharmacies

    Mairead McArdle -
    February 24, 2017 4:44 am
    0
    The e-cigarette sector can't come anywhere close to affording the costs associated with regulatory barriers.
    Beltway Confidential

    Hope for vapers: New bill could halt FDA e-cigarette prohibition

    Guy Bentley -
    February 16, 2017 8:30 pm
    0
    CEO says drugmaker will meet with advocates to explain company's plans and review the community's concerns. (AP Photo/Sue Ogrocki, File)
    Healthcare

    $89,000 drug delays launch

    Robert King -
    February 13, 2017 11:01 pm
    0
    The Food and Drug Administration gave the nod to 22 new medications, after approving 45 in 2015. (AP Photo/Julio Cortez, File)
    Healthcare

    $89,000 price of new drug gets lawmakers riled up

    Robert King -
    February 13, 2017 7:06 pm
    0
    The U.S. and the U.K. have different thoughts on the use and sale of e-cigarettes. (AP Photo/Nam Y. Huh, File)
    Beltway Confidential

    What the US can learn from the UK about vaping

    Guy Bentley -
    February 10, 2017 1:00 pm
    0
    Misinformation surrounding e-cigarettes has become so pervasive that public understanding has gone into reverse. (AP Photo/Rich Pedroncelli)
    Beltway Confidential

    How Trump can stop e-cigarette prohibition and reform public health

    Guy Bentley -
    January 31, 2017 7:50 pm
    0
    In 2016, the FDA announced it would be shelling out $36 million on a campaign to inform young people that
    Beltway Confidential

    FDA must come clean about the real risks of smokeless tobacco

    Guy Bentley -
    January 30, 2017 9:59 pm
    0
    A White House aide says the freeze applies
    Healthcare

    Hiring freeze hits FDA positions not funded by taxpayers

    Robert King -
    January 29, 2017 5:00 am
    0
    Grace Stuntz is the senior Food and Drug Administration policy adviser for the Senate Health, Education, Labor and Pensions Committee. (Graeme Jennings/Washington Examiner)
    Healthcare

    Congressional staffer profile: How Grace Stuntz went from the lab to Congress

    Robert King -
    January 16, 2017 5:01 am
    0
    1...134135136...180Page 135 of 180
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.